Last checked at 1 Jun 2020 15:00
1 June 2020 15:00 BST
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 1 June 2020
Name of applicant: | ASTRAZENECA PLC | |||
Name of scheme: | ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS-RELATED SHARE OPTION PLAN; ASTRAZENECA ALL-EMPLOYEE SHARE PLAN; ASTRAZENECA PLC 2012 SAVINGS-RELATED SHARE OPTION SCHEME | |||
Period of return: | From: | 1 December 2019 | To: | 31 May 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 1,111,666 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 348,131 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 763,535 | |||
Name of contact: | CAMILLA JOHNSTONE |
Telephone number of contact: | 020 3749 5000 |
AstraZeneca
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Adrian KempCompany Secretary
AstraZeneca PLC